PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations

Saved in:
Bibliographic Details
Published inValue in health Vol. 15; no. 7; p. A415
Main Authors Culig, J, Leppée, M, Skaron-Jakobovic, N
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.11.2012
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2012.08.1230